IDNK

Across TCGA pan-cancer cohorts, IDNK Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated IDNK data layer compared with 29 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher IDNK Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated IDNK expression acts as an unfavorable survival marker.

READ, LUAD, and UCEC are the cancer types where IDNK Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	All	0.173	0.828	<.001	39	view →
LUAD	OS	Median	All	0.342	0.685	.029	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

IDNK–READ (OS)

Open the READ breakdown →